Brooks Bahr, MD
Dermatology · Bountiful, UTNPI 1831326941
Payments from drug & device makers
Across 92 payments — averaging $19.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$322
- AbbVie$256
- Johnson & Johnson$237
- Lilly USA, LLC$172
- Prugen, Inc. Pharmaceuticals$139
- LEO Pharma Inc.$131
- plus $534 from 14 others
What the payments were for
- Food & beverage$1,62691%
- Education$1659%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 17 | $322 |
| AbbVie(2 entities) | 14 | $256 |
| Johnson & Johnson | 6 | $237 |
| Lilly USA, LLC | 10 | $172 |
| Prugen, Inc. Pharmaceuticals | 12 | $139 |
| LEO Pharma Inc. | 6 | $131 |
| UCB, Inc. | 2 | $74 |
| Dermavant Sciences, Inc. | 4 | $70 |
| VYNE Pharmaceuticals Inc. | 2 | $64 |
| Arcutis Biotherapeutics, Inc. | 3 | $60 |
| Organon | 4 | $47 |
| Galderma Laboratories, L.p. | 2 | $34 |
| E.r. Squibb & Sons, L.L.C. | 2 | $33 |
| Sun Pharmaceutical Industries Inc. | 2 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Merz North America, Inc. | 1 | $26 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $21 |
| Dermira, Inc. | 1 | $18 |
| Botanix SB Inc | 1 | $17 |
| Pfizer | 1 | $13 |
How this compares
$1,791 in reported general payments places this provider in the 60th percentile of 163 dermatology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 90 | $3,433 |
| Metronidazole | 47 | $2,090 |
| Doxycycline Monohydrate | 114 | $1,985 |
| Fluocinonide | 48 | $1,819 |
| Triamcinolone Acetonide | 147 | $1,755 |
| Ketoconazole | 107 | $1,624 |
| Minoxidil | 80 | $1,286 |
| ValacyclovirValacyclovir Hcl | 14 | $1,033 |
| Clindamycin Phosphate | 31 | $975 |
| Mupirocin | 31 | $507 |
| Doxepin Hcl | 16 | $341 |
| Hydrocortisone | 40 | $328 |
| Terbinafine Hcl | 29 | $328 |
| MethotrexateMethotrexate Sodium | 16 | $271 |
| Cephalexin | 15 | $231 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Bountiful
- Jason HadleyBountiful$477K
- Jamie RhoadsMurray$2.5M
- Doug Lass ForshaWest Jordan$2.2M
- Michael PetersonSpanish Fork$1.6M
- Kristina DuffinSalt Lake City$1.2M
- Gerald KruegerSalt Lake City$1.1M
- Brian WilliamsMidvale$876K
- Mark TaylorSalt Lake City$473K
- Travis JamesProvidence$472K
- Douglas WosethSalt Lake$466K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.